About CathPCI Risk Calculator
CathPCI Risk Calculator was an overall app developed by American College of Cardiology. It was removed from Google Play May 11, 2026 and is no longer available for download.
Download Statistics
User Ratings
The app had no ratings.
App Information
CathPCI Risk Calculator was free to download. The APK download size was 21.14 MB. The last available version was 2.0. The last update was on May 23, 2023.
Technical Requirements
The app had a content rating of High Maturity. The app had been available on Google Play April 2017.
More data about CathPCI Risk Calculator
| Price | Free to download |
| Rating | No ratings |
| Version | 2.0 |
| App download size | 21.1 MB |
| Maturity | High Maturity |
Also available on Google Play
Alternative downloads for the CathPCI Risk Calculator app
SCAI Point-of-Care App
More from American College of Cardiology
Changelog of CathPCI Risk Calculator
No changelog data
Developer information for American College of Cardiology
American College of Cardiology
Address:
Comments on CathPCI Risk Calculator for iOS
We don't have enough comments to show example comments. Please check back later.
Technologies used by CathPCI Risk Calculator
Frequently asked questions about CathPCI Risk Calculator
Is CathPCI Risk Calculator free?
Yes. CathPCI Risk Calculator is free to download from App Store.
Is CathPCI Risk Calculator still available?
No. CathPCI Risk Calculator was removed from App Store. We last saw it there May 11, 2026.
How large is the CathPCI Risk Calculator download?
CathPCI Risk Calculator is 21.14 MB to download.
Is CathPCI Risk Calculator suitable for children?
App Store gives CathPCI Risk Calculator a high maturity rating. It is meant for adults.
Who made CathPCI Risk Calculator?
CathPCI Risk Calculator was developed by American College of Cardiology. It is listed in the overall category on App Store.
What are the best alternatives to CathPCI Risk Calculator?
People looking at CathPCI Risk Calculator also look at these overall apps: SCAI Point-of-Care App, Cardiac Trials, IVUSAID, BifurcAID 3D, ASNC Guidelines and Standards.
Back to top